Rectal complications after prostate brachytherapy

Diseases of the Colon and Rectum

Volumn 47, Issue 9, 2004, Pages 1487-1492

  Shah, Shimul A ^a,b   Cima, Robert R ^a,b   Benoit, Eric ^a   Breen, Elizabeth L ^a   Bleday, Ronald ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Colostomy; Prostate brachytherapy; Prostate cancer; Radiation proctitis; Rectal urethral fistula

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BEAM THERAPY; BLOOD TRANSFUSION; BRACHYTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL PROTOCOL; COLOSTOMY; COMORBIDITY; CORONARY ARTERY DISEASE; DIARRHEA; ENTEROCUTANEOUS FISTULA; HEART INFARCTION; HUMAN; ILEOSTOMY; INCIDENCE; INTESTINE PERFORATION; MALE; OUTCOMES RESEARCH; PAIN; POSTOPERATIVE COMPLICATION; PROSTATE CARCINOMA; RADIATION INJURY; RECTUM DISEASE; RECTUM FISTULA; RECTUM ULCER; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; STOMA; SURGICAL TECHNIQUE; SYMPTOM; TRANSURETHRAL RESECTION; URETHRA FISTULA;

AGED; BRACHYTHERAPY; COMORBIDITY; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RADIATION INJURIES; RECTAL FISTULA; RISK FACTORS; TIME FACTORS; URINARY FISTULA;

EID: 4644265212     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10350-004-0603-2     Document Type: Article

References (14)

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000;50:7-33.
2. Sylvester J, Blasko JC, Grimm P, Ragde H. Interstitial implantation techniques in prostate cancer. J Surg Oncol 1997;66:65-75.
3. Blasko JC, Wallner KE, Grimm PD, Ragde H. PSA-based disease control following ultrasound-guided I-125 implantation for stage T1/T2 prostate carcinoma. J Urol 1995;154:1096-9.
4. Wallner KE, Roy J, Harrison L. Tumor control and morbidity following transperineal I-125 implantation for Stage T1/T2 prostate carcinoma. J Clin Oncol 1996;14:1449-53.
5. Nag S, Beyer D, Friedland J, Grimm P, Nath R. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys 1999;44:789-99.
6. Stock RG, Stone NN. Permanent radioactive seed implantation in the treatment of prostate cancer. Hematol Oncol Clin North Am 1999;13:489-501.
7. Gelblum DY, Potters L. Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2000;48:119-24.
8. Jordan GH, Lynch DF, Warden SS, McGraw JD, Hoffman GC, Schellhammer PF. Major rectal complications following interstitial implantation of 125Iodine for carcinoma of the prostate. J Urol 1985;134:1212-5.
9. Kleinberg L, Wallner K, Roy J, et al. Treatment-related symptoms during the first year following transperineal 125I prostate implantation. Int J Radiat Oncol Biol Phys 1994;28:985-90.
10. Stone NN, Stock RG. Complications following permanent prostate brachytherapy. Eur Urol 2002;41:427-33.
11. Kang SK, Chou RH, Dodge RK, et al. Gastrointestinal toxicity of transperineal interstitial prostate brachytherapy. Int J Radiat Oncol Biol Phys 2002;53:99-103.
12. Theodorescu D, Gillenwater JY, Koutrouvelis PG. Prostatourethral-rectal fistula after prostate brachytherapy. Cancer 2000;89:2085-91.
13. Smathers S, Wallner K, Simpson C, Roof J. Patient perception of local anesthesia for prostate brachytherapy. Semin Urol Oncol 2000;18:142-6.
14. Hu K, Wallner K. Clinical course of rectal bleeding following I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys 1998;41:263-5.